Quercetin attenuates mitochondrial dysfunction and biogenesis via upregulated AMPK/SIRT1 signaling pathway in OA rats

Biomedicine and Pharmacotherapy

Volumn 103, Issue , 2018, Pages 1585-1591

  Qiu, Linan ^a   Luo, Yuju ^a   Chen, Xiaojuan ^a  

^a DAQING OILFIELD CO LTD   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; COLLAGENASE 3; GLUTATHIONE; GLUTATHIONE PEROXIDASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; INTERLEUKIN 2; MITOCHONDRIAL DNA; NITRIC OXIDE; OXYGEN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; QUERCETIN; REACTIVE OXYGEN METABOLITE; SIRTUIN 1; STROMELYSIN; ADENYLATE KINASE;

AMPK SIGNALING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; ARTICULAR CARTILAGE; CATABOLISM; CONTROLLED STUDY; COPY NUMBER VARIATION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; EXTRACELLULAR MATRIX; MALE; MITOCHONDRIAL BIOGENESIS; MITOCHONDRIAL MEMBRANE POTENTIAL; NONHUMAN; OSTEOARTHRITIS; PRIORITY JOURNAL; PROTEIN ACETYLATION; RAT; RAT MODEL; REMISSION; UPREGULATION; ANIMAL; CHONDROCYTE; DRUG EFFECT; GENETICS; METABOLISM; MITOCHONDRION; ORGANELLE BIOGENESIS; PATHOLOGY; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT;

ADENYLATE KINASE; ANIMALS; CHONDROCYTES; DNA, MITOCHONDRIAL; MALE; MEMBRANE POTENTIAL, MITOCHONDRIAL; MITOCHONDRIA; ORGANELLE BIOGENESIS; OSTEOARTHRITIS; QUERCETIN; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; SIRTUIN 1; UP-REGULATION;

EID: 85046818282     PISSN: 07533322     EISSN: 19506007     Source Type: Journal    
DOI: 10.1016/j.biopha.2018.05.003     Document Type: Article

References (35)

1. Cross, M., Smith, E., Hoy, D., Nolte, S., Ackerman, I., Fransen, M., Bridgett, L., Williams, S., Guillemin, F., Hill, C.L., Laslett, L.L., Jones, G., Cicuttini, F., Osborne, R., Vos, T., Buchbinder, R., Woolf, A., March, L., The global burden of hip and knee osteoarthritis: estimates from the global burden of disease 2010 study. Ann. Rheum. Dis. 73 (2014), 1323–1330.
2. Bingham, C.O. 3rd, Buckland-Wright, J.C., Garnero, P., Cohen, S.B., Dougados, M., Adami, S., Clauw, D.J., Spector, T.D., Pelletier, J.P., Raynauld, J.P., Strand, V., Simon, L.S., Meyer, J.M., Cline, G.A., Beary, J.F., Risedronate decreases biochemical markers of cartilage degradation but does not decrease symptoms or slow radiographic progression in patients with medial compartment osteoarthritis of the knee: results of the two-year multinational knee osteoarthritis structural arthritis study. Arthritis Rheum. 54 (2006), 3494–3507.
3. Davis, M.A., Ettinger, W.H., Neuhaus, J.M., Hauck, W.W., Sex differences in osteoarthritis of the knee. The role of obesity. Am. J. Epidemiol. 127 (1988), 1019–1030.
4. Valdes, A.M., Spector, T.D., The genetic epidemiology of osteoarthritis. Curr. Opin. Rheumatol. 22 (2010), 139–143.
5. Maruotti, N., Corrado, A., Cantatore, F.P., Osteoblast role in osteoarthritis pathogenesis. J. Cell. Physiol., 2017.
6. Felson, D.T., Lawrence, R.C., Dieppe, P.A., Hirsch, R., Helmick, C.G., Jordan, J.M., Kington, R.S., Lane, N.E., Nevitt, M.C., Zhang, Y., Sowers, M., McAlindon, T., Spector, T.D., Poole, A.R., Yanovski, S.Z., Ateshian, G., Sharma, L., Buckwalter, J.A., Brandt, K.D., Fries, J.F., Osteoarthritis: new insights. Part 1: the disease and its risk factors. Ann. Intern. Med. 133 (2000), 635–646.
7. Malfait, A.M., Osteoarthritis year in review 2015: biology. Osteoarthr. Cartil. 24 (2016), 21–26.
8. Moir, H., Hughes, M.G., Potter, S., Sims, C., Butcher, L.R., Davies, N.A., Verheggen, K., Jones, K.P., Thomas, A.W., Webb, R., Exercise-induced immunosuppression: roles of reactive oxygen species and 5’-AMP-activated protein kinase dephosphorylation within immune cells. J. Appl. Physiol. 108:2010 (1985), 1284–1292.
9. de Rezende, M.U., de Campos, G.C., Pailo, A.F., Current concepts in osteoarthritis. Acta Ortop. Bras. 21 (2013), 120–122.
10. Henrotin, Y.E., Bruckner, P., Pujol, J.P., The role of reactive oxygen species in homeostasis and degradation of cartilage. Osteoarthr. Cartil. 11 (2003), 747–755.
11. Greenwald, R.A., Oxygen radicals, inflammation, and arthritis: pathophysiological considerations and implications for treatment. Semin. Arthritis Rheum. 20 (1991), 219–240.
12. Martin, J.A., Brown, T., Heiner, A., Buckwalter, J.A., Post-traumatic osteoarthritis: the role of accelerated chondrocyte senescence. Biorheology 41 (2004), 479–491.
13. Martin, J.A., Brown, T.D., Heiner, A.D., Buckwalter, J.A., Chondrocyte senescence, joint loading and osteoarthritis. Clin. Orthop. Relat. Res., 2004, S96–103.
14. Haklar, U., Yuksel, M., Velioglu, A., Turkmen, M., Haklar, G., Yalcin, A.S., Oxygen radicals and nitric oxide levels in chondral or meniscal lesions or both. Clin. Orthop. Relat. Res., 2002, 135–142.
15. Kawai, Y., Kubota, E., Okabe, E., Reactive oxygen species participation in experimentally induced arthritis of the temporomandibular joint in rats. J. Dent. Res. 79 (2000), 1489–1495.
16. Goldring, M.B., Berenbaum, F., The regulation of chondrocyte function by proinflammatory mediators: prostaglandins and nitric oxide. Clin. Orthop. Relat. Res., 2004, S37–46.
17. Dimock, A.N., Siciliano, P.D., McIlwraith, C.W., Evidence supporting an increased presence of reactive oxygen species in the diseased equine joint. Equine Vet. J. 32 (2000), 439–443.
18. Terkeltaub, R., Yang, B., Lotz, M., Liu-Bryan, R., Chondrocyte AMP-activated protein kinase activity suppresses matrix degradation responses to proinflammatory cytokines interleukin-1beta and tumor necrosis factor alpha. Arthritis Rheum. 63 (2011), 1928–1937.
19. Hosseinzadeh, A., Kamrava, S.K., Joghataei, M.T., Darabi, R., Shakeri-Zadeh, A., Shahriari, M., Reiter, R.J., Ghaznavi, H., Mehrzadi, S., Apoptosis signaling pathways in osteoarthritis and possible protective role of melatonin. J. Pineal Res. 61 (2016), 411–425.
20. Chung, H.Y., Cesari, M., Anton, S., Marzetti, E., Giovannini, S., Seo, A.Y., Carter, C., Yu, B.P., Leeuwenburgh, C., Molecular inflammation: underpinnings of aging and age-related diseases. Ageing Res. Rev. 8 (2009), 18–30.
21. Kienhofer, J., Haussler, D.J., Ruckelshausen, F., Muessig, E., Weber, K., Pimentel, D., Ullrich, V., Burkle, A., Bachschmid, M.M., Association of mitochondrial antioxidant enzymes with mitochondrial DNA as integral nucleoid constituents. FASEB J. 23 (2009), 2034–2044.
22. Terao, J., Kawai, Y., Murota, K., Vegetable flavonoids and cardiovascular disease. Asia Pac. J. Clin. Nutr. 17:Suppl. 1 (2008), 291–293.
23. Huang, W.Y., Fu, L., Li, C.Y., Xu, L.P., Zhang, L.X., Zhang, W.M., Quercetin, hyperin, and chlorogenic acid improve endothelial function by antioxidant, antiinflammatory, and ACE inhibitory effects. J. Food Sci., 2017.
24. Ma, Y., Sun, X., Huang, K., Shen, S., Lin, X., Xie, Z., Wang, J., Fan, S., Ma, J., Zhao, X., Sanguinarine protects against osteoarthritis by suppressing the expression of catabolic proteases. Oncotarget, 2017.
25. Li, D., Xie, G., Wang, W., Reactive oxygen species: the 2-edged sword of osteoarthritis. Am. J. Med. Sci. 344 (2012), 486–490.
26. Lepetsos, P., Papavassiliou, A.G., ROS/oxidative stress signaling in osteoarthritis. Biochim. Biophys. Acta 1862 (2016), 576–591.
27. Fattman, C.L., Schaefer, L.M., Oury, T.D., Extracellular superoxide dismutase in biology and medicine. Free Radic. Biol. Med. 35 (2003), 236–256.
28. Betteridge, D.J., What is oxidative stress?. Metabolism 49 (2000), 3–8.
29. Zhang, J.L., Laurence Souders, C. 2nd, Denslow, N.D., Martyniuk, C.J., Quercetin, a natural product supplement, impairs mitochondrial bioenergetics and locomotor behavior in larval zebrafish (Danio rerio). Toxicol. Appl. Pharmacol., 2017.
30. Munro, D., Treberg, J.R., A radical shift in perspective: mitochondria as regulators of reactive oxygen species. J. Exp. Biol. 220 (2017), 1170–1180.
31. Turrens, J.F., Mitochondrial formation of reactive oxygen species. J. Physiol. 552 (2003), 335–344.
32. Han, J., Wang, W., Qu, C., Liu, R., Li, W., Gao, Z., Guo, X., Role of inflammation in the process of clinical Kashin-Beck disease: latest findings and interpretations. Inflamm. Res. 64 (2015), 853–860.
33. Burrage, P.S., Mix, K.S., Brinckerhoff, C.E., Matrix metalloproteinases: role in arthritis. Front. Biosci. 11 (2006), 529–543.
34. Zhao, X., Petursson, F., Viollet, B., Lotz, M., Terkeltaub, R., Liu-Bryan, R., Peroxisome proliferator-activated receptor gamma coactivator 1alpha and FoxO3A mediate chondroprotection by AMP-activated protein kinase. Arthritis Rheumatol. 66 (2014), 3073–3082.
35. Wang, Y., Zhao, X., Lotz, M., Terkeltaub, R., Liu-Bryan, R., Mitochondrial biogenesis is impaired in osteoarthritis chondrocytes but reversible via peroxisome proliferator-activated receptor gamma coactivator 1alpha. Arthritis Rheumatol. 67 (2015), 2141–2153.